Pharmaceutical company “Farmak” (Kyiv) is considering the possibility of contract manufacturing of active pharmaceutical ingredients (APIs) in Shostka (Sumy region), have informed Agency “Interfax-Ukraine” CEO Augustine Dubnicka.

“We consider projects for contract manufacturing of APIs at our facilities in Shostka. Are in the process of negotiations with some producers,” he said.

As noted A. Dubnicka, currently in this area there is high competition due to large production capacity of API in China and India.

“When our company will be ready to sell are made in these capacity afy for the markets of Europe and the United States, we plan to organize in Shostka inspection from U.S. FDA (Management on sanitary inspection behind quality of foodstuff and medicines – if), as well as on the European Directorate for the quality of medicines and healthcare,” he said.

Farmak is a member of the Association “Manufacturers of drugs of Ukraine” (APLU ).

Full text of interview read on the main page, the Agency “Interfax-Ukraine”